Some people may be considering filing Medtronic Insulin Pump lawsuits due to their injuries.The November 2019 Medtronic insulin pump recall is only the latest in a history of recalls involving MiniMed insulin pumps.© 2020 - Seeger Weiss | All Rights Reserved.On November 21, 2019, the FDA issued a safety alert notifying the medical community and public about a Class 1 recall issued by medical device maker Medtronic. The recall may affect an estimated 322,005 insulin pumps in the U.S.The current recall concerns a newer type of pump which are designed to be used as part of a “closed-loop” system which automatically detects blood sugar levels and delivers insulin without the user’s intervention. The automated system was approved in as the MiniMed 670G in September 2016 as the first “artificial pancreas” type pumps. While most of these lawsuits were settled or resolved, the company may be facing a new round of lawsuits filed by people who have been injured by the MiniMed 630G or 670G Insulin Pump.The affected MiniMed insulin pump uses a retainer ring to lock the cartridge or reservoir which contains the supply of insulin in place. On November 21, 2019, the FDA issued a safety alert notifying the public and medical professionals of the new MiniMed Insulin Pump recall.Even though Medtronic’s technology continues to advance, serious risks have continued to occur. On November 18, 2017, the FDA announced a Class 2 device recall for over 9.5 million Medtronic MimiMed Infusion sets.A Class II recall is an immediate threat level recall and identifies products that might cause a temporary health problem. If not locked securely, the device may over or under deliver insulin to the patient. Some of these people or others who were injured by the MiniMed Insulin Pump malfunction may be considering lawsuits and should seek legal assistance.Of the 322,005 pumps which may be affected by the recall, there have been 26,421 error reports which included 2,175 injuries and at least one death which have been received by the FDA. The ring is required to lock or secure the cartridge reservoir which contains the insulin supply, into place. With offices in New York, New Jersey and Philadelphia, our firm is primarily known for multidistrict mass torts and class actions in both state and federal courts, with a strong track record of landmark verdicts and settlements.The FDA has said that the pumps have been involved in 26,421 complaints involving 2,175 injuries and one death. Seeger Weiss’ websites and social media accounts are designed for general information only. No aspect of this or any advertisement has been approved by the Supreme Court of New Jersey. The information contained on Seeger Weiss’ websites and social media accounts should not be construed as legal advice, should not be relied upon as a substitute for the retention of an attorney or for independent legal research, and does not create an attorney-client relationship. MiniMed Insulin Pump Recall Lawsuit. The materials presented by this website are not medical advice, and are not a substitute for the opinion of a qualified healthcare professional. Both overdosage which may result in hypoglycemia, and underdosage which may result in hyperglycemia, are possible. If you are a legal copyright holder and believe a page on this site falls outside the boundaries of “Fair Use” and infringes on your client’s copyright, we can be contacted regarding copyright matters at admin@consumersafetyguide.comIn November of 2019, the U.S. Food and Drug Administration (FDA) announced a Class I recall of Medtronic MiniMed Insulin Pumps.